Compare NBIX & AVAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBIX | AVAV |
|---|---|---|
| Founded | 1992 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 14.0B |
| IPO Year | 1996 | 2007 |
| Metric | NBIX | AVAV |
|---|---|---|
| Price | $135.92 | $343.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 21 | 15 |
| Target Price | $177.29 | ★ $367.47 |
| AVG Volume (30 Days) | 1.0M | ★ 1.4M |
| Earning Date | 02-05-2026 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.44 | N/A |
| EPS | ★ 4.19 | N/A |
| Revenue | ★ $2,682,700,000.00 | $1,369,870,000.00 |
| Revenue This Year | $23.68 | $148.35 |
| Revenue Next Year | $18.47 | $17.03 |
| P/E Ratio | $33.55 | ★ N/A |
| Revenue Growth | 19.61 | ★ 79.89 |
| 52 Week Low | $84.23 | $102.25 |
| 52 Week High | $160.18 | $417.86 |
| Indicator | NBIX | AVAV |
|---|---|---|
| Relative Strength Index (RSI) | 36.26 | 73.48 |
| Support Level | $134.03 | $239.80 |
| Resistance Level | $142.16 | $263.36 |
| Average True Range (ATR) | 3.13 | 14.79 |
| MACD | -1.09 | 12.66 |
| Stochastic Oscillator | 11.91 | 80.43 |
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.